HCA Holdings weakness overdone, says RW Baird After HCA reported higher than expected Q2 EPS but its stock fell due to concerns about a critical New York Times story, HCA believes that the decline is overdone, given what it sees as the company's strong fundamentals and market share gains. The firm maintains a $31 target and Outperform rating on the stock.
News For HCA From The Last 14 Days
Check below for free stories on HCA the last two weeks.